专利检索 ap:("ARMGO Pharma, Inc.") AND inv:"Jérôme Binet" 第 1 页

1.

发明授权
Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof 有权

公开(公告)号：US12059426B2

公开(公告)日：2024-08-13

申请号：US18221784

申请日：2023-07-13

申请人： ARMGO Pharma, Inc.

发明人： Eugene E. Marcantonio , Mette Uhre Anby , Jérôme Binet

IPC分类号： A61K31/554 , A61K9/28 , A61P21/00

CPC分类号： A61K31/554 , A61K9/2866 , A61K9/2886 , A61P21/00

摘要： The present disclosure provides a modified-release pharmaceutical composition comprising 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, and a pharmaceutically-acceptable excipient. The present disclosure methods of treating conditions associated with RyRs, including, for example, cardiac disorder or disease, a musculoskeletal disorder or disease, cancer associated muscle weakness, malignant hyperthermia, and diabetes.

2.

发明授权
Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof 有权

公开(公告)号：US11717526B2

公开(公告)日：2023-08-08

申请号：US17748886

申请日：2022-05-19

申请人： ARMGO Pharma, Inc.

发明人： Eugene E. Marcantonio , Mette Uhre Anby , Jérôme Binet

IPC分类号： A61K31/554 , A61P21/00 , A61K9/28

CPC分类号： A61K31/554 , A61K9/2866 , A61K9/2886 , A61P21/00

摘要： The present disclosure provides a modified-release pharmaceutical composition comprising 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, and a pharmaceutically-acceptable excipient. The present disclosure methods of treating conditions associated with RyRs, including, for example, cardiac disorder or disease, a musculoskeletal disorder or disease, cancer associated muscle weakness, malignant hyperthermia, and diabetes.